Skip to main content
Lifeward Ltd. logo

Lifeward Ltd. — Investor Relations & Filings

Ticker · LFWD ISIN · IL0011331076 US Manufacturing
Open in API
Filings indexed 815 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country US United States of America
Listing US LFWD

About Lifeward Ltd.

https://golifeward.com/

Lifeward Ltd. is a medical device company that designs, develops, and commercializes solutions for physical rehabilitation and recovery. The company's portfolio is focused on technologies for individuals with lower limb disabilities and other physical limitations. Key products include powered exoskeletons for personal and clinical use, exo-suits for gait training, and Functional Electrical Stimulation (FES) cycling systems. These solutions are designed to span the continuum of care, aiming to improve mobility, function, and health for users in both rehabilitation settings and daily life.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 91% confidence The document is labeled “FORM SD – Specialized Disclosure Report” filed under SEC Rule 13p-1 for conflict minerals disclosure. It is not an Annual Report, Earnings Release, Interim Report, or other financial report, but a regulatory compliance form. Thus, it falls under the generic Regulatory Filings category.
2026-05-29 English
S-8
Share Issue/Capital Change Classification · 85% confidence The document is a Securities and Exchange Commission Form S-8 registration statement under the Securities Act of 1933, filed to register additional ordinary shares under an employee incentive compensation plan and to note a 1-for-12 reverse share split. It is not an annual report, earnings release, management change notice or proxy material, but a filing to register and authorize new share issuances and record a capital structure change. This best fits the “Share Issue/Capital Change” category (SHA).
2026-05-20 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-20 English
8-K
Board/Management Information Classification · 92% confidence The document is an SEC Form 8-K current report, specifically Item 8.01 “Other Events,” announcing the appointment of a new Chief Medical Officer (Keith D. Rose). This is an announcement of a senior management change, which falls under Board/Management Information (MANG).
2026-05-19 English
8-K
Earnings Release Classification · 92% confidence The document is a Form 8-K Current Report announcing and furnishing a press release with the company’s first quarter financial results (ended March 31, 2026). It is not the full interim report itself nor an investor presentation or transcript, but the initial public announcement of quarterly results, which matches the definition of an Earnings Release. Q1 2026
2026-05-15 English
8-K - Lifeward Ltd. (0001607962) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes the resignation of a board member and audit committee member, the resulting non-compliance with Nasdaq listing rules, and the subsequent appointment of new audit committee members restoring compliance. This is an announcement of changes in the company's board and audit committee membership, which fits the category of Board/Management Information (MANG). The document length is 3644 characters, which is relatively short and consistent with a current report rather than a full annual or interim report. There is no detailed financial data or earnings information, so it is not an earnings release or financial report. Therefore, the correct classification is MANG with high confidence.
2026-03-31 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.